# Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers

> **NCT03383211** · — · COMPLETED · sponsor: **George Washington University** · enrollment: 125 (actual)

## Conditions studied

- HIV Infections
- Neonatal Infection
- LTBI - Latent Tuberculosis Infection
- Immune Tolerance

## Interventions

- **OTHER:** RNAseq

## Key facts

- **NCT ID:** NCT03383211
- **Lead sponsor:** George Washington University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-16
- **Primary completion:** 2020-09-01
- **Final completion:** 2021-06-30
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2021-10-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03383211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03383211, "Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03383211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*